Acumen Pharmaceuticals (ABOS) Capital Expenditures (2021 - 2025)

Acumen Pharmaceuticals' Capital Expenditures history runs 5 years deep, the most recent figure standing at $88000.0 for Q3 2025.

• In Q3 2025, Capital Expenditures changed N/A year-over-year to $88000.0; the TTM figure through Mar 2026 stood at $9000.0 (down 47.06% YoY), while the FY2025 annual figure was $88000.0, up 450.0% from the prior year.
• Capital Expenditures came in at $88000.0 for Q3 2025 at Acumen Pharmaceuticals, up from -$79000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $88000.0 in Q3 2025 to a low of -$79000.0 in Q2 2025.
• A 5-year average of $24615.4 and a median of $26000.0 in 2021 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures surged 950.0% in 2022 and slumped 91.67% in 2023, its largest moves.
• Acumen Pharmaceuticals' Capital Expenditures stood at $26000.0 in 2021, then soared by 34.62% to $35000.0 in 2022, then sank by 60.0% to $14000.0 in 2023, then plunged by 542.86% to -$62000.0 in 2024, then surged by 241.94% to $88000.0 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered $88000.0, -$79000.0, and $79000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison